GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients

Journal of Pediatric Endocrinology & Metabolism : JPEM
Hugo L FideleffHugo R Boquete

Abstract

To study two subsets of patients with GH deficiency (GHD) during the transition period: childhood onset GHD (CO-GHD) and patients who develop GHD during the transition phase (TO-GHD) before and after GH replacement. In 1340 GHD subjects from KIMS (Pfizer International Metabolic Database), CO (n=586) or TO (n=754), background characteristics, anthropometric measurements, IGF-1, lipids and quality of life (QoL) were evaluated at baseline and after 3 years of GH replacement. Both groups responded similarly to GH treatment. Changes of clinical outcomes were mainly determined by their value at baseline. Onset of the disease in childhood or transition period did not appear to be a significant predictor of response in any of the clinical outcomes. Age at GHD diagnosis was a significant predictor for many outcomes at baseline, but disease onset did not appear as an independent predictor concerning changes after 3 years of GH treatment. The results suggest that GH replacement during the transition period should be considered independently of the onset of the deficiency.

References

Sep 3, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S P McKennaL Wíren
Sep 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Stephen M ShaletAndrea F Attanasio
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Louis E UnderwoodUNKNOWN Genentech Collaborative Study Group
Feb 15, 2005·New Review of Bioethics·Povl Riis
Mar 5, 2005·European Journal of Endocrinology·P E ClaytonUNKNOWN European Society of Paediatric Endocrinology
Jun 24, 2006·European Journal of Endocrinology·Maria Koltowska-HäggströmGudmundur Johannsson
Mar 29, 2007·Hormone Research·K Kaushal, S M Shalet
Apr 6, 2007·The Journal of Clinical Endocrinology and Metabolism·Sally Radovick, Sara DiVall
Jun 15, 2007·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Peter ClaytonJ Sandahl Christiansen
Oct 25, 2007·Pharmacoepidemiology and Drug Safety·Lia P GutiérrezAnton Luger
Nov 7, 2007·European Journal of Endocrinology·Charlotte HoybyeRoger Abs
Nov 22, 2008·European Journal of Endocrinology·Ze'ev Hochberg
Jun 5, 2010·Endocrine Development·Nelly Mauras

❮ Previous
Next ❯

Citations

Jan 10, 2018·Frontiers in Endocrinology·Berthold P HauffaEkaterina Koledova
Aug 14, 2013·European Journal of Endocrinology·Carine CourtillotUNKNOWN Transition GHD Group
Apr 20, 2014·European Journal of Endocrinology·Marie-Luise EggertNele Friedrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved